1. Home
  2. RLAY vs EH Comparison

RLAY vs EH Comparison

Compare RLAY & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$11.98

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
EH
Founded
2015
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
RLAY
EH
Price
$9.15
$11.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$15.75
$21.85
AVG Volume (30 Days)
2.5M
694.9K
Earning Date
02-24-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,355,000.00
$60,400,607.00
Revenue This Year
$19.96
$10.53
Revenue Next Year
N/A
$81.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.39
52 Week Low
$1.78
$11.23
52 Week High
$9.25
$29.76

Technical Indicators

Market Signals
Indicator
RLAY
EH
Relative Strength Index (RSI) 59.52 37.37
Support Level $8.08 $11.23
Resistance Level $9.25 $12.43
Average True Range (ATR) 0.67 0.45
MACD 0.12 -0.09
Stochastic Oscillator 83.02 25.32

Price Performance

Historical Comparison
RLAY
EH

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Share on Social Networks: